Alliance Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Alliance Pharma generated cash of $31,410,000, which is more than the previous year. Cash used in financing activities reached the amount of -$39,193,000 last year. Net change in cash is therefore -$9,278,000.
Cash Flow
| 2014 | 11.42M | -3.36M | -5.62M |
|---|---|---|---|
| 2015 | 7.97M | -134.36M | 128.48M |
| 2016 | 16.92M | -8.02M | -5.46M |
| 2017 | 26.58M | -15.91M | -6.45M |
| 2018 | 22.17M | -59.08M | 36.58M |
| 2019 | 35.75M | -3.28M | -25.19M |
| 2020 | 41.56M | -85.86M | 55.74M |
| 2021 | 38.65M | -4.59M | -34.34M |
| 2022 | 20.97M | -17.02M | -876K |
| 2023 | 31.41M | -918K | -39.19M |
APH.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 31.71M | 29.06M | 28.89M | 17.83M | 10.89M | 11.18M | 7.22M | 3.19M | 1.02M | -1.43M |
Operating activities | ||||||||||
Net income | -33.13M | 936K | 7.31M | 8.02M | 25.01M | 18.35M | 28.91M | 22.21M | 15.18M | 10.15M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 10.32M | 10.76M | 16.25M | 20.96M | 1.95M | 7.79M | 933K | 429K | 438K | 1.41M |
Stock-based compensation expense | 889K | 92K | 2.25M | 1.37M | 1.81M | 0 | 1.45M | 696K | 615K | 571K |
| Deferred income tax benefit | 889K | 92K | 2.25M | 1.37M | 1.81M | 0 | 1.45M | 696K | 615K | 571K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -6.48M | -18.72M | -6.14M | 6.72M | -498K | -7.62M | 4.01M | -14.11M | -3.30M | 0 |
Inventories | -1.85M | -2.20M | 1.84M | -5.20M | 2.03M | -4.45M | 1.10M | -2.44M | -6.99M | -446K |
Accounts payable | 1.93M | 7.28M | -326K | 5.92M | -3.80M | 5.05M | -2.99M | 10.08M | 2.31M | 0 |
Cash generated by operating activities | 31.41M | 20.97M | 38.65M | 41.56M | 35.75M | 22.17M | 26.58M | 16.92M | 7.97M | 11.42M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -500K | -3.62M | -154K | -1.01M | 0 | 0 |
Investments In Property Plant And Equipment | -696K | -607K | -5.53M | -4.61M | -4.15M | -2.93M | -2.69M | -1.39M | -134.28M | -2.98M |
Acquisitions Net | -222K | -16.61M | 183K | -82.66M | 500K | -58.61M | -17.47M | -6.02M | -221K | -499K |
Cash generated by investing activities | -918K | -17.02M | -4.59M | -85.86M | -3.28M | -59.08M | -15.91M | -8.02M | -134.36M | -3.36M |
Financing activities | ||||||||||
Common Stock Issued | 37K | 341K | 736K | 1.64M | 4.50M | 34.81M | 682K | 1.33M | 83.62M | 8K |
Payments for dividends | -9.59M | -9.11M | -8.60M | -2.83M | -7.59M | 0 | -5.72M | -5.15M | -2.64M | -2.39M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.76M |
Repayments of term debt | -18M | 13.66M | -22.58M | -21.54M | -17.47M | -15.81M | 816K | -6.49M | 52.5M | -4.5M |
Cash used in financing activities | -39.19M | -876K | -34.34M | 55.74M | -25.19M | 36.58M | -6.45M | -5.46M | 128.48M | -5.62M |
Net Change In Cash | -9.27M | 2.65M | 163K | 11.06M | 6.93M | -291K | 3.96M | 4.02M | 2.17M | 2.45M |
Cash at end of period | 22.43M | 31.71M | 29.06M | 28.89M | 17.83M | 10.89M | 11.18M | 7.22M | 3.19M | 1.02M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |